Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) rose 5.9% during mid-day trading on Thursday. The company traded as high as $43.76 and last traded at $43.76. 250 shares were traded during mid-day trading, a decline of 81% from the average session volume of 1,320 shares. The stock had previously closed at $41.31.
Hikma Pharmaceuticals Stock Performance
The company’s 50-day moving average price is $43.27 and its 200 day moving average price is $39.79.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures and markets a broad range of medicines. Founded in Jordan in 1978 by Samih Darwazah, the company has grown from a regional business into an international healthcare group serving patients and healthcare providers in markets across North America, Europe and the Middle East and North Africa.
Hikma operates through three principal businesses: Injectables, Generics and Branded Medicines. Its products include injectable medicines used in hospitals and other clinical settings, generic prescription medicines, and branded and licensed pharmaceutical products for a range of therapeutic areas.
Further Reading
- Five stocks we like better than Hikma Pharmaceuticals
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
- Best Buy Is Turning Amazon Fire TV Into a New Advertising Opportunity
- MarketBeat Week in Review – 09/21 – 09/25
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
